| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 10.91M | — |
| Operating expense | — | — |
| Net income | -10.24M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PTHS returned +16.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -15.2% |
| 1 year | +16.9% |
| All-time high | $37.70 (Feb 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PTHS would be worth today ›No. Pelthos Therapeutics Inc. has not paid a dividend in the past 12 months.
Pelthos Therapeutics Inc. stock trades on NYSEAMERICAN under the ticker symbol PTHS.
Pelthos Therapeutics Inc. is part of the Healthcare sector.
Pelthos Therapeutics Inc. has a market cap of 100.69M USD, based on the latest quote.
Pelthos Therapeutics Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
